Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.49)
# 882
Out of 4,876 analysts
40
Total ratings
47.5%
Success rate
6.92%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRXS NeurAxis | Initiates: Buy | $7 | $2.52 | +177.78% | 1 | Jun 16, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $12 → $17 | $9.55 | +78.01% | 2 | Jun 9, 2025 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $12 → $13 | $8.26 | +57.38% | 5 | May 14, 2025 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $28 | $13.96 | +100.57% | 6 | May 14, 2025 | |
| XERS Xeris Biopharma Holdings | Maintains: Buy | $5 → $6.5 | $4.74 | +37.13% | 1 | Mar 7, 2025 | |
| MDWD MediWound | Initiates: Buy | $39 | $19.43 | +100.72% | 1 | Feb 28, 2025 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $10 → $8 | $0.78 | +928.01% | 4 | Jan 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $14.05 | +49.47% | 2 | Jan 17, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $5 → $6 | $3.58 | +67.60% | 2 | Jan 17, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $3.98 | +201.51% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.58 | +179.33% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $13.69 | +16.87% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $65 | $31.35 | +107.34% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $5.94 | +102.02% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $7.71 | +29.70% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $9.29 | +147.71% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.62 | +94.87% | 2 | Jul 11, 2023 |
NeurAxis
Jun 16, 2025
Initiates: Buy
Price Target: $7
Current: $2.52
Upside: +177.78%
Phathom Pharmaceuticals
Jun 9, 2025
Maintains: Buy
Price Target: $12 → $17
Current: $9.55
Upside: +78.01%
Fennec Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $12 → $13
Current: $8.26
Upside: +57.38%
Eton Pharmaceuticals
May 14, 2025
Maintains: Buy
Price Target: $26 → $28
Current: $13.96
Upside: +100.57%
Xeris Biopharma Holdings
Mar 7, 2025
Maintains: Buy
Price Target: $5 → $6.5
Current: $4.74
Upside: +37.13%
MediWound
Feb 28, 2025
Initiates: Buy
Price Target: $39
Current: $19.43
Upside: +100.72%
Ironwood Pharmaceuticals
Jan 22, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.78
Upside: +928.01%
Delcath Systems
Jan 17, 2025
Maintains: Buy
Price Target: $18 → $21
Current: $14.05
Upside: +49.47%
KORU Medical Systems
Jan 17, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $3.58
Upside: +67.60%
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $3.98
Upside: +201.51%
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $3.58
Upside: +179.33%
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $13.69
Upside: +16.87%
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $31.35
Upside: +107.34%
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $5.94
Upside: +102.02%
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $7.71
Upside: +29.70%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $9.29
Upside: +147.71%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.62
Upside: +94.87%